NeuroSense Therapeutics reported total assets of $1.03M and total liabilities of $2.59M for the quarter ended Dec 2025, down 44.2% year over year. This balance sheet covers 16 quarters of results from Dec 2020 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2020 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Jun2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Current Assets | ||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 0.70M | 0.70M | 8.73M | 4.35M | 4.41M | 3.54M | 1.36M | 7.09M | 4.76M | 3.54M | 0.73M | 1.21M | 0.34M | 3.38M | 0.67M | 0.17M |
| Short-term InvestmentsInvestments (Current) | 0.04M | 0.04M | 0.06M | 0.02M | 0.02M | -0.02M | 0.04M | 0.04M | 0.04M | -0.00M | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M | 0.05M |
| Cash & Current Investments | 0.74M | 0.74M | 8.80M | 4.37M | 4.43M | 3.52M | 1.40M | 7.13M | 4.80M | 3.54M | 0.77M | 1.24M | 0.38M | 3.41M | 0.71M | 0.21M |
| Receivables - NetNet Receivables | 0.03M | 0.31M | 0.26M | 0.24M | ||||||||||||
| Receivables - OtherOther Receivables | 0.03M | 0.08M | 0.23M | 0.71M | 0.42M | 0.26M | 0.57M | 0.43M | 0.31M | 0.24M | 0.42M | 0.38M | 0.41M | 0.99M | 0.85M | 0.56M |
| Receivables | 0.06M | 0.39M | 0.51M | 0.47M | ||||||||||||
| Inventory | 0.74M | 0.45M | ||||||||||||||
| Prepaid Assets | 0.07M | 0.09M | 0.08M | |||||||||||||
| Current Assets | 0.77M | 11.41M | 14.03M | 11.10M | 8.89M | 7.38M | 5.02M | 7.56M | 5.11M | 2.92M | 1.19M | 1.62M | 0.79M | 4.40M | 1.56M | 0.78M |
| Non-Current Assets | ||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.01M | 0.02M | 0.33M | 0.35M | 0.34M | 0.34M | 0.32M | 0.31M | 0.28M | 0.27M | 0.25M | 0.22M | 0.20M | 0.17M | 0.13M | 0.25M |
| Long-Term Investments | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | ||||||||||
| Goodwill & Intangibles | 0.01M | 0.02M | ||||||||||||||
| Long-Term Deferred Tax | 0.95M | 1.65M | 3.31M | |||||||||||||
| Non-Current Assets | 0.01M | 0.02M | 0.33M | 0.35M | 0.34M | 0.34M | 0.32M | 0.31M | 0.28M | 0.27M | 0.25M | 0.22M | 0.20M | 0.17M | 0.13M | 0.25M |
| Assets | 0.78M | 11.43M | 14.36M | 11.45M | 9.23M | 7.72M | 5.33M | 7.87M | 5.39M | 3.19M | 1.45M | 1.84M | 0.98M | 4.58M | 1.68M | 1.03M |
| Liabilities | ||||||||||||||||
| Current Liabilities | ||||||||||||||||
| Accounts Payables | 0.06M | 0.04M | 0.18M | 0.12M | 0.21M | 0.50M | 0.42M | 1.09M | 0.91M | 1.46M | 2.38M | 1.48M | 1.39M | 1.16M | 1.09M | 0.80M |
| Payables | 0.06M | 0.04M | 0.18M | 0.12M | 0.21M | 0.50M | 0.42M | 1.09M | 0.91M | 1.46M | 2.38M | 1.48M | 1.39M | 1.16M | 1.09M | 0.80M |
| Accumulated Expenses | 0.03M | 0.44M | 0.37M | 1.48M | 0.50M | 1.16M | ||||||||||
| Other Accumulated Expenses | 0.07M | 0.56M | 1.05M | 0.62M | 0.60M | 1.23M | 1.37M | 1.92M | 1.90M | 2.00M | 2.15M | 2.02M | 2.39M | 0.83M | 1.11M | 1.72M |
| Total Current Liabilities | 0.12M | 0.60M | 1.23M | 0.74M | 0.81M | 1.73M | 1.79M | 3.00M | 2.81M | 3.46M | 4.54M | 3.51M | 3.78M | 1.99M | 2.20M | 2.52M |
| Non-Current Liabilities | ||||||||||||||||
| Operating Leases | 0.21M | 0.19M | 0.17M | 0.15M | 0.13M | 0.10M | 0.08M | 0.07M | 0.06M | 0.04M | 0.02M | 0.07M | 0.07M | |||
| Other Non-Current Liabilities | 1.41M | |||||||||||||||
| Total Non-Current Liabilities | 1.83M | 0.88M | 0.15M | 6.41M | 1.49M | 0.04M | 0.07M | |||||||||
| Total Liabilities | 0.12M | 2.42M | 2.25M | 1.62M | 1.38M | 1.87M | 2.45M | 9.41M | 5.58M | 4.94M | 8.44M | 3.54M | 3.80M | 1.99M | 2.20M | 2.59M |
| Shareholder's Equity | ||||||||||||||||
| Common Equity | 0.66M | 10.83M | 12.11M | 9.84M | 7.85M | 5.84M | 2.89M | 1.27M | -0.20M | -1.76M | -6.99M | -1.70M | -2.82M | 2.58M | -0.52M | -1.56M |
| Liabilities and Shareholders Equity | 0.78M | 11.43M | 14.36M | 11.45M | 9.23M | 7.72M | 5.33M | 7.87M | 5.39M | 3.19M | 1.45M | 1.84M | 0.98M | 4.58M | 1.68M | 1.03M |
| Retained Earnings | -4.41M | -8.45M | -11.16M | -14.64M | -17.64M | -16.01M | -24.68M | -29.90M | -29.12M | -26.12M | -31.52M | -32.38M | -34.53M | -36.66M | -41.37M | -47.78M |
Pull NeuroSense Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=NRSN&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "NRSN", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=NRSN&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();